SCHEMBL7418539

SCHEMBL7418539

N[C@@H]([C]=O)CC1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.37
ALOX5 P09917 2/20 0.36
DPP4 P27487 1/20 0.35
SLC1A3 P43003 2/20 0.34
SLC1A2 P43004 2/20 0.34
SLC1A1 P43005 2/20 0.34
METAP2 P50579 2/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504941 1.00 METAP1 (0.37) METAP1ALOX5DPP4SLC1A3SLC1A2
SCHEMBL1449256 1.00 METAP1 (0.37) METAP1ALOX5DPP4SLC1A3SLC1A2
SCHEMBL7375737 0.98 ALOX5 (0.34) METAP1ALOX5DPP4SLC1A3SLC1A2
SCHEMBL7375837 0.93
SCHEMBL7608856 0.88
SCHEMBL8943205 0.80 CPB2 (0.36)
SCHEMBL2640244 0.80 CPB2 (0.36)
SCHEMBL21211687 0.79 KDM4E (0.38) METAP1CTSK
SCHEMBL27534752 0.79 KDM4E (0.38) METAP1CTSK
SCHEMBL7105061 0.78 METAP1 (0.52) METAP1ALOX5METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0564588-B1 HEXAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS ABBOTT LAB (US) 1997-02-12 EP claimed
US-5387671-A Antiinflammatory agents ABBOTT LABORATORIES (US) 1995-02-07 US claimed
US-5386011-A Antiinflammatory agents; also, peptidomimetic compounds, i,e., agonists, having immunoregulatory effect against infections and cancer ABBOTT LABORATORIES (US) 1995-01-31 US claimed
EP-0564588-A4 HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS 1993-12-29 EP claimed
EP-0564588-A1 HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS. ABBOTT LAB (US) 1993-10-13 EP claimed
US-5140009-A Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders TAP PHARMACEUTICALS, INC. (US) 1992-08-18 US claimed
WO-1992011858-A1 HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 1992-07-23 WO claimed
WO-1992012168-A1 MODIFIED HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 1992-07-23 WO claimed
EP-3472130-A1 ALIPHATIC PROLINAMIDE DERIVATIVES ORION OPTHALMOLOGY LLC (US) 2019-04-24 EP disclosed
WO-2017222917-A1 ALIPHATIC PROLINAMIDE DERIVATIVES INCEPTION 4, INC. (US) 2017-12-28 WO disclosed
EP-0564588-B1 HEXAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS ABBOTT LAB (US) 1997-02-12 EP disclosed
US-5387671-A Antiinflammatory agents ABBOTT LABORATORIES (US) 1995-02-07 US disclosed
US-5386011-A Antiinflammatory agents; also, peptidomimetic compounds, i,e., agonists, having immunoregulatory effect against infections and cancer ABBOTT LABORATORIES (US) 1995-01-31 US disclosed
US-5190922-A Antiinflammatory ABBOTT LABORATORIES (US) 1993-03-02 US disclosed
WO-1992021361-A1 TERMINALLY MODIFIED TRI-, TETRA- AND PENTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 1992-12-10 WO disclosed
WO-1992011858-A1 HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN-RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 1992-07-23 WO disclosed
WO-1992012168-A1 MODIFIED HEXA- AND HEPTAPEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 1992-07-23 WO disclosed